Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mariateresa Fulciniti, Ph.D.

Concepts (402)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mariateresa Fulciniti's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mariateresa Fulciniti has written about over time.
Mice, SCID, 19 publications between 2006 and 2018, average publication date March 2011. Transcriptional Activation, 3 publications between 2009 and 2014, average publication date August 2011. Cell Survival, 13 publications between 2007 and 2018, average publication date December 2011. Sp1 Transcription Factor, 2 publications between 2011 and 2014, average publication date November 2012. Cell Proliferation, 21 publications between 2006 and 2023, average publication date December 2013. Acrylamides, 3 publications between 2012 and 2018, average publication date December 2014. Nicotinamide Phosphoribosyltransferase, 3 publications between 2012 and 2018, average publication date December 2014. Waldenstrom Macroglobulinemia, 5 publications between 2011 and 2021, average publication date June 2015. Cell Line, Tumor, 33 publications between 2006 and 2024, average publication date October 2015. Multiple Myeloma, 68 publications between 2004 and 2024, average publication date July 2016. Antineoplastic Agents, 13 publications between 2006 and 2024, average publication date September 2016. Receptor, Fibroblast Growth Factor, Type 3, 1 publications between 2017 and 2017, average publication date January 2017. Gene Expression Regulation, Neoplastic, 19 publications between 2009 and 2024, average publication date August 2017. p21-Activated Kinases, 2 publications between 2017 and 2018, average publication date November 2017. Enhancer Elements, Genetic, 2 publications between 2018 and 2018, average publication date July 2018. Aminopyridines, 1 publications between 2018 and 2018, average publication date September 2018. Mesenchymal Stem Cells, 3 publications between 2008 and 2024, average publication date December 2018.

To see the data from this visualization as text, click here.
Fulciniti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (402)
Explore
_
Co-Authors (68)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.